The purpose of this study is to determine the pharmacokinetics and bioequivalence of isotretinoin formulations after administration of single doses to normal, non-smoking,healthy males under fed conditions
An open label, randomized, two-treatment, single dose, oral bioequivalence study of Isotretinoin capsules 40 mg of Dr. Reddy's Laboratories Limited,under fed conditions
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
26
Isotretinoin Capsules,40 mg
AAI
Quadrangle Drive, Chapel Hill,, North Carolina, United States
Area under curve (AUC)
Time frame: Pre-dose (0) and 0.5, 1,1.5,2,2.5,3,4,5,6,7,8,11,14,18, 24,36,48,72 and 96 hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.